629
Participants
Start Date
April 30, 2004
Primary Completion Date
March 31, 2005
Study Completion Date
April 30, 2005
clevidipine
nitroglycerin
New York University Medical Center, New York
St Joseph Medical Center, Towson
Inova Fairfax Hospital, Falls Church
Virginia Commonwealth University Medical Center, Richmond
Sacred Heart Health System, Pensacola
Health First Holmes Regional Medical Center, Melbourne
Regional Medical Center - Bayonet Point, Hudson
Brookwood Medical Center, Birmingham
Baptist Medical Center, Montclair, Birmingham
Medical Center East, Birmingham
Baptist Medical Center, South, Montgomery
Sterling Research Group, Ltd., Cincinnati
The Christ Hospital, The Linder Clinical Trial Center, Cincinnati
Henry Ford Health System, Detroit
Saint Francis Hospital, Evanston
Wesley Medical Center, Wichita
Memorial Herman Memorial City Hospital, Houston
The Methodist Hospital, Houston
Houston Northwest Medical Center, Houston
University Medical Center, Tucson
Keck School of Medicine, University of Southern California, Los Angeles
Huntington Memorial Hospital, Pasadena
Saddleback Memorial Medical Center, Laguna Hills
Kaiser Permanente Moanalua Medical Center, Honolulu
Portland VA Medical Center, Portland
Saint Joseph Medical Center, Tacoma
University of California, San Francisco
Michael E DeBakey VA Medical Center, Houston
Lead Sponsor
The Medicines Company
INDUSTRY